Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem
OBJECTIVE: To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures. CASE SUMMARY: A 21-year-old woman presented to our emergency department because of a new-onset, generalized tonic—clonic seizure and was admitted to the intensive c...
Gespeichert in:
| Veröffentlicht in: | The Annals of pharmacotherapy 2005-03, Vol.39 (3), p.533-537 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 537 |
|---|---|
| container_issue | 3 |
| container_start_page | 533 |
| container_title | The Annals of pharmacotherapy |
| container_volume | 39 |
| creator | Coves-Orts, Francisco Javier Borras-Blasco, Joaquin Navarro-Ruiz, Andres Murcia-Lopez, Ana Palacios-Ortega, Francisco |
| description | OBJECTIVE:
To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures.
CASE SUMMARY:
A 21-year-old woman presented to our emergency department because of a new-onset, generalized tonic—clonic seizure and was admitted to the intensive care unit. Treatment with valproic acid 1000 mg as a continuous intravenous infusion over 24 hours was initiated. On day 6, the serum concentration of valproic acid was 52.5 μg/mL. On day 13, treatment with intravenous meropenem 1 g 3 times daily was started. On day 15, when the patient was afebrile, numerous myoclonic episodes occurred involving her arms and face; the serum concentration of valproic acid at that time was 42 μg/mL. The valproic acid dose was increased to 2880 mg. Two days later, a generalized tonic—clonic seizure occurred despite the increased dosage, and the plasma concentration of valproic acid fell to 7 μg/mL. The valproic acid dose was increased the following day to 3600 mg; however, the serum concentrations remained |
| doi_str_mv | 10.1345/aph.1E358 |
| format | Article |
| fullrecord | <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1345_aph_1E358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.1E358</sage_id><sourcerecordid>10.1345_aph.1E358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-3d62d58c6eb5659f19230602eaa945bda261491dc796c226a3fa0d92f5d77e263</originalsourceid><addsrcrecordid>eNptkE1P4zAQhi0EogX2sH9g5QtIHAL-iJ36WD52FwkE0n5crYk9oanSJLITRfDr8W4r9cJp5vDofWceQr5ydsVlrq6hX13xe6kWB2TOVS4yLQp2mHamWcbEgs3ISYxrxpjhwhyTGVcF44U2c_KydOOA9BfW72PASO9GpENHgb6EroSyQfrQDhjADXXX0hscJsSW_oWmD13t6NLVnkLr6ROGrscWN2fkqIIm4pfdPCV_vt__vv2ZPT7_eLhdPmYuz9mQSa-FVwunsVRamYobIdO1AgFMrkoPQvPccO8Ko50QGmQFzBtRKV8UKLQ8JZfbXBe6GANWtg_1BsKb5cz-s2KTFfvfSmK_bdl-LDfo9-ROQwLOdwBEB00VoHV13HPpwmIhWOIutlyEV7Trbgxt-vHTxl3gqn5dTXVAGzfQNKmf22mapLHSKinlB702gpk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Coves-Orts, Francisco Javier ; Borras-Blasco, Joaquin ; Navarro-Ruiz, Andres ; Murcia-Lopez, Ana ; Palacios-Ortega, Francisco</creator><creatorcontrib>Coves-Orts, Francisco Javier ; Borras-Blasco, Joaquin ; Navarro-Ruiz, Andres ; Murcia-Lopez, Ana ; Palacios-Ortega, Francisco</creatorcontrib><description>OBJECTIVE:
To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures.
CASE SUMMARY:
A 21-year-old woman presented to our emergency department because of a new-onset, generalized tonic—clonic seizure and was admitted to the intensive care unit. Treatment with valproic acid 1000 mg as a continuous intravenous infusion over 24 hours was initiated. On day 6, the serum concentration of valproic acid was 52.5 μg/mL. On day 13, treatment with intravenous meropenem 1 g 3 times daily was started. On day 15, when the patient was afebrile, numerous myoclonic episodes occurred involving her arms and face; the serum concentration of valproic acid at that time was 42 μg/mL. The valproic acid dose was increased to 2880 mg. Two days later, a generalized tonic—clonic seizure occurred despite the increased dosage, and the plasma concentration of valproic acid fell to 7 μg/mL. The valproic acid dose was increased the following day to 3600 mg; however, the serum concentrations remained <10 μg/mL. On day 19, based on the results of a blood culture and the suspicion of an interaction between meropenem and valproic acid, meropenem therapy was suspended. The serum concentration of valproic acid was 52.4 μg/mL on day 27. Three days later, the patient was asymptomatic and was discharged.
DISCUSSION:
Coadministration of valproic acid and other drugs that are metabolized by the hepatic cytochrome P450 isoenzyme system can lead to clinically relevant interactions by induction or inhibition of enzymes in shared metabolic pathways. In view of studies in experimental models, the interaction between carbapenem antibiotics and valproic acid is at least possible. Use of the Naranjo probability scale indicated a probable relationship between acute seizures and a meropenem—valproic acid interaction in this patient.
CONCLUSIONS:
This case report provides strong evidence for an interaction between valproic acid and meropenem. Clinicians should be aware of this potential interaction that may be associated with a serious adverse effect as the result of the decrease of the valproic acid serum concentrations.</description><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1E358</identifier><identifier>PMID: 15701769</identifier><identifier>CODEN: APHRER</identifier><language>eng</language><publisher>Los Angeles, CA: Harvey Whitney Books</publisher><subject>Acute Disease ; Adult ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - metabolism ; Anticonvulsants - adverse effects ; Anticonvulsants - blood ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Drug Interactions ; Epilepsy - chemically induced ; Female ; Humans ; Infusions, Intravenous ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments ; Seizures - drug therapy ; Thienamycins - adverse effects ; Thienamycins - metabolism ; Valproic Acid - adverse effects ; Valproic Acid - blood</subject><ispartof>The Annals of pharmacotherapy, 2005-03, Vol.39 (3), p.533-537</ispartof><rights>2005 SAGE Publications</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-3d62d58c6eb5659f19230602eaa945bda261491dc796c226a3fa0d92f5d77e263</citedby><cites>FETCH-LOGICAL-c440t-3d62d58c6eb5659f19230602eaa945bda261491dc796c226a3fa0d92f5d77e263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1345/aph.1E358$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1345/aph.1E358$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16597820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15701769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coves-Orts, Francisco Javier</creatorcontrib><creatorcontrib>Borras-Blasco, Joaquin</creatorcontrib><creatorcontrib>Navarro-Ruiz, Andres</creatorcontrib><creatorcontrib>Murcia-Lopez, Ana</creatorcontrib><creatorcontrib>Palacios-Ortega, Francisco</creatorcontrib><title>Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><description>OBJECTIVE:
To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures.
CASE SUMMARY:
A 21-year-old woman presented to our emergency department because of a new-onset, generalized tonic—clonic seizure and was admitted to the intensive care unit. Treatment with valproic acid 1000 mg as a continuous intravenous infusion over 24 hours was initiated. On day 6, the serum concentration of valproic acid was 52.5 μg/mL. On day 13, treatment with intravenous meropenem 1 g 3 times daily was started. On day 15, when the patient was afebrile, numerous myoclonic episodes occurred involving her arms and face; the serum concentration of valproic acid at that time was 42 μg/mL. The valproic acid dose was increased to 2880 mg. Two days later, a generalized tonic—clonic seizure occurred despite the increased dosage, and the plasma concentration of valproic acid fell to 7 μg/mL. The valproic acid dose was increased the following day to 3600 mg; however, the serum concentrations remained <10 μg/mL. On day 19, based on the results of a blood culture and the suspicion of an interaction between meropenem and valproic acid, meropenem therapy was suspended. The serum concentration of valproic acid was 52.4 μg/mL on day 27. Three days later, the patient was asymptomatic and was discharged.
DISCUSSION:
Coadministration of valproic acid and other drugs that are metabolized by the hepatic cytochrome P450 isoenzyme system can lead to clinically relevant interactions by induction or inhibition of enzymes in shared metabolic pathways. In view of studies in experimental models, the interaction between carbapenem antibiotics and valproic acid is at least possible. Use of the Naranjo probability scale indicated a probable relationship between acute seizures and a meropenem—valproic acid interaction in this patient.
CONCLUSIONS:
This case report provides strong evidence for an interaction between valproic acid and meropenem. Clinicians should be aware of this potential interaction that may be associated with a serious adverse effect as the result of the decrease of the valproic acid serum concentrations.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - metabolism</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - blood</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Drug Interactions</subject><subject>Epilepsy - chemically induced</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Seizures - drug therapy</subject><subject>Thienamycins - adverse effects</subject><subject>Thienamycins - metabolism</subject><subject>Valproic Acid - adverse effects</subject><subject>Valproic Acid - blood</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1P4zAQhi0EogX2sH9g5QtIHAL-iJ36WD52FwkE0n5crYk9oanSJLITRfDr8W4r9cJp5vDofWceQr5ydsVlrq6hX13xe6kWB2TOVS4yLQp2mHamWcbEgs3ISYxrxpjhwhyTGVcF44U2c_KydOOA9BfW72PASO9GpENHgb6EroSyQfrQDhjADXXX0hscJsSW_oWmD13t6NLVnkLr6ROGrscWN2fkqIIm4pfdPCV_vt__vv2ZPT7_eLhdPmYuz9mQSa-FVwunsVRamYobIdO1AgFMrkoPQvPccO8Ko50QGmQFzBtRKV8UKLQ8JZfbXBe6GANWtg_1BsKb5cz-s2KTFfvfSmK_bdl-LDfo9-ROQwLOdwBEB00VoHV13HPpwmIhWOIutlyEV7Trbgxt-vHTxl3gqn5dTXVAGzfQNKmf22mapLHSKinlB702gpk</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Coves-Orts, Francisco Javier</creator><creator>Borras-Blasco, Joaquin</creator><creator>Navarro-Ruiz, Andres</creator><creator>Murcia-Lopez, Ana</creator><creator>Palacios-Ortega, Francisco</creator><general>Harvey Whitney Books</general><general>SAGE Publications</general><general>Whitney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050301</creationdate><title>Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem</title><author>Coves-Orts, Francisco Javier ; Borras-Blasco, Joaquin ; Navarro-Ruiz, Andres ; Murcia-Lopez, Ana ; Palacios-Ortega, Francisco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-3d62d58c6eb5659f19230602eaa945bda261491dc796c226a3fa0d92f5d77e263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - metabolism</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - blood</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Drug Interactions</topic><topic>Epilepsy - chemically induced</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Seizures - drug therapy</topic><topic>Thienamycins - adverse effects</topic><topic>Thienamycins - metabolism</topic><topic>Valproic Acid - adverse effects</topic><topic>Valproic Acid - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coves-Orts, Francisco Javier</creatorcontrib><creatorcontrib>Borras-Blasco, Joaquin</creatorcontrib><creatorcontrib>Navarro-Ruiz, Andres</creatorcontrib><creatorcontrib>Murcia-Lopez, Ana</creatorcontrib><creatorcontrib>Palacios-Ortega, Francisco</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coves-Orts, Francisco Javier</au><au>Borras-Blasco, Joaquin</au><au>Navarro-Ruiz, Andres</au><au>Murcia-Lopez, Ana</au><au>Palacios-Ortega, Francisco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>39</volume><issue>3</issue><spage>533</spage><epage>537</epage><pages>533-537</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><coden>APHRER</coden><abstract>OBJECTIVE:
To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures.
CASE SUMMARY:
A 21-year-old woman presented to our emergency department because of a new-onset, generalized tonic—clonic seizure and was admitted to the intensive care unit. Treatment with valproic acid 1000 mg as a continuous intravenous infusion over 24 hours was initiated. On day 6, the serum concentration of valproic acid was 52.5 μg/mL. On day 13, treatment with intravenous meropenem 1 g 3 times daily was started. On day 15, when the patient was afebrile, numerous myoclonic episodes occurred involving her arms and face; the serum concentration of valproic acid at that time was 42 μg/mL. The valproic acid dose was increased to 2880 mg. Two days later, a generalized tonic—clonic seizure occurred despite the increased dosage, and the plasma concentration of valproic acid fell to 7 μg/mL. The valproic acid dose was increased the following day to 3600 mg; however, the serum concentrations remained <10 μg/mL. On day 19, based on the results of a blood culture and the suspicion of an interaction between meropenem and valproic acid, meropenem therapy was suspended. The serum concentration of valproic acid was 52.4 μg/mL on day 27. Three days later, the patient was asymptomatic and was discharged.
DISCUSSION:
Coadministration of valproic acid and other drugs that are metabolized by the hepatic cytochrome P450 isoenzyme system can lead to clinically relevant interactions by induction or inhibition of enzymes in shared metabolic pathways. In view of studies in experimental models, the interaction between carbapenem antibiotics and valproic acid is at least possible. Use of the Naranjo probability scale indicated a probable relationship between acute seizures and a meropenem—valproic acid interaction in this patient.
CONCLUSIONS:
This case report provides strong evidence for an interaction between valproic acid and meropenem. Clinicians should be aware of this potential interaction that may be associated with a serious adverse effect as the result of the decrease of the valproic acid serum concentrations.</abstract><cop>Los Angeles, CA</cop><pub>Harvey Whitney Books</pub><pmid>15701769</pmid><doi>10.1345/aph.1E358</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1060-0280 |
| ispartof | The Annals of pharmacotherapy, 2005-03, Vol.39 (3), p.533-537 |
| issn | 1060-0280 1542-6270 |
| language | eng |
| recordid | cdi_crossref_primary_10_1345_aph_1E358 |
| source | Access via SAGE; MEDLINE |
| subjects | Acute Disease Adult Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - metabolism Anticonvulsants - adverse effects Anticonvulsants - blood Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Drug Interactions Epilepsy - chemically induced Female Humans Infusions, Intravenous Medical sciences Neuropharmacology Pharmacology. Drug treatments Seizures - drug therapy Thienamycins - adverse effects Thienamycins - metabolism Valproic Acid - adverse effects Valproic Acid - blood |
| title | Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Seizures%20Due%20to%20a%20Probable%20Interaction%20Between%20Valproic%20Acid%20and%20Meropenem&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Coves-Orts,%20Francisco%20Javier&rft.date=2005-03-01&rft.volume=39&rft.issue=3&rft.spage=533&rft.epage=537&rft.pages=533-537&rft.issn=1060-0280&rft.eissn=1542-6270&rft.coden=APHRER&rft_id=info:doi/10.1345/aph.1E358&rft_dat=%3Csage_cross%3E10.1345_aph.1E358%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15701769&rft_sage_id=10.1345_aph.1E358&rfr_iscdi=true |